Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein in Brain Cell Cytoplasm Protects against Necrosis

By LabMedica International staff writers
Posted on 16 Nov 2011
High levels of the protein Nmnat 1 (nicotinamide mononucleotide adenylyl transferase 1) in the cytoplasm of brain cells protect these cells from damage caused by reduced blood flow and oxygen deprivation, conditions that can cause cerebral palsy in newborns.

Investigators at Washington University School of Medicine (St. More...
Louis, MO, USA) created a line of genetically engineered mice that overexpressed the gene for Nmnat 1 and exposed these animals to conditions that mimicked human infantile cerebral palsy.

They reported in the November 4, 2011, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that as early as six hours after experiencing oxygen deprivation the genetically engineered mice had strikingly less injury detected by MRI as compared to similarly treated normal control animals. Furthermore, the genetically engineered mice had markedly less injury in their hippocampus, cortex, and striatum than wild-type mice as assessed by loss of tissue volume seven days after injury.

“There are two types of injury in the developing brain from inadequate oxygen and blood flow,” said senior author Dr. David M. Holtzman professor of neurology at Washington University School of Medicine. “One is necrosis, where cells swell rapidly, burst, and die; another is apoptosis, where the cells shrink and die. We found that Nmnat1 prevents necrosis.”

“Under normal circumstances, the brain can handle a temporary disruption of either oxygen or blood flow during birth, but when they occur together and for long enough, long-term disability and death can result,” said Dr. Holtzman. “If we can use drugs to trigger the same protective pathway as Nmnat1, it may be possible to prevent brain damage that occurs from these conditions as well as from neurodegenerative diseases.”

Related Links:

Washington University School of Medicine



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.